Skip to main content
. 2022 Jan 18;12:789319. doi: 10.3389/fphar.2021.789319

FIGURE 4.

FIGURE 4

Treatment ranking and relative effects of systemic treatments from subgroup analyses on overall survival. (A) patient age≥65 years, (B) patient age<65 years, (C) patients with an ECOG score<2, (D) patients with a ECOG score≥2, (E) patients without visceral metastases, (F) patients with visceral metastases.